Genomma Lab Internacional SAB de CV
BMV:LABB

Watchlist Manager
Genomma Lab Internacional SAB de CV Logo
Genomma Lab Internacional SAB de CV
BMV:LABB
Watchlist
Price: 25.46 MXN -0.51% Market Closed
Market Cap: 25.5B MXN
Have any thoughts about
Genomma Lab Internacional SAB de CV?
Write Note

Genomma Lab Internacional SAB de CV
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genomma Lab Internacional SAB de CV
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Genomma Lab Internacional SAB de CV
BMV:LABB
PP&E Net
Mex$3.5B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
23%
No Stocks Found

Genomma Lab Internacional SAB de CV
Glance View

Market Cap
24.1B MXN
Industry
Pharmaceuticals

Nestled amid the dynamic landscape of the Mexican pharmaceutical and personal care market, Genomma Lab Internacional SAB de CV has carved a distinct niche for itself since its inception in 1996. The company, recognized for its innovative approach to marketing and product distribution, operates with a dual business model that focuses both on over-the-counter (OTC) medications and a slew of personal care products. This strategic diversification has enabled Genomma Lab to tap into a broad array of consumer needs, expanding its reach beyond the confines of Mexico to a wide array of markets across the Latin American region and beyond. By leveraging a robust distribution network, which includes traditional retailers and modern trade channels, Genomma ensures that its products – from headache remedies to skincare solutions – are easily accessible to consumers, thereby driving consistent revenue growth. Central to Genomma Lab's success is its ability to blend strategic marketing prowess with an agile supply chain. The company's marketing campaigns are meticulously crafted, often highlighting the efficacy and trustworthiness of its products, which resonates well with a cost-sensitive yet quality-oriented consumer base. Furthermore, Genomma Lab thrives on an innovative product pipeline that sees continual introductions and adaptations in response to changing market demands. This commitment to innovation is complemented by cost efficiency in its operations, allowing the company to maintain competitive pricing. With an entrenched brand presence and a solid track record of adaptability, Genomma Lab continues to bolster its market position, focusing on both organic growth and strategic alliances to propel its evolution in the global marketplace.

LABB Intrinsic Value
29.88 MXN
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Genomma Lab Internacional SAB de CV's PP&E Net?
PP&E Net
3.5B MXN

Based on the financial report for Sep 30, 2024, Genomma Lab Internacional SAB de CV's PP&E Net amounts to 3.5B MXN.

What is Genomma Lab Internacional SAB de CV's PP&E Net growth rate?
PP&E Net CAGR 10Y
23%

Over the last year, the PP&E Net growth was 2%. The average annual PP&E Net growth rates for Genomma Lab Internacional SAB de CV have been 3% over the past three years , 10% over the past five years , and 23% over the past ten years .

Back to Top